Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | Director | April 20, 2026 | April 21, 2026 |
| CERUS CORPCERS · Entity 5431 | Director | June 02, 2026 | June 02, 2026 |
| REVVITY, INC.RVTY · Entity 3382 | Director | May 07, 2026 | May 11, 2026 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Director | June 18, 2026 | June 23, 2026 |
| Telesis Bio Inc.TBIO · Entity 15606 | Director | July 06, 2023 | May 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date April 20, 2026 · Filed April 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2031-04-20 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Other · Disposed 49,627 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2031-04-20 | Direct | 49,627 |
Reported balance
After 2026-04-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-20 · Other · Acquired 49,627 · Balance 49,627 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.10 · Expires 2035-04-15 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-20 · Other · Disposed 33,085 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.10 · Expires 2035-04-15 | Direct | 33,085 |
Reported balance
After 2026-04-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-20 · Other · Acquired 33,085 · Balance 33,085 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2036-01-14 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-20 · Other · Disposed 124,069 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2036-01-14 | Direct | 124,069 |
Reported balance
After 2026-04-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-20 · Other · Acquired 124,069 · Balance 124,069 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
F2: Fully vested.
F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
CERUS CORP
Report date June 02, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 340,059 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 60,000 · Balance 340,059 F1: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
REVVITY, INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,354 |
Ending reported balance
After 2026-05-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-07 · Grant · Acquired 1,015 · Balance 22,089 F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Row 2 · 2026-05-07 · Grant · Acquired 1,265 · Balance 23,354 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control.
STANDARD BIOTOOLS INC.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 309,978 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 99,116 · Balance 309,978 F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.83 · Expires 2036-06-18 | Direct | 175,923 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Grant · Acquired 175,923 · Balance 175,923 F3: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,225 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,225 F2: Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2: Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
F3: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Telesis Bio Inc.
Report date July 06, 2023 · Filed May 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,736 |
Ending reported balance
After 2024-05-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-07-06 · Grant · Acquired 46,752 · Balance 67,382 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Row 2 · 2024-05-01 · Grant · Acquired 48,354 · Balance 115,736 F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 28,113 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.54 · Expires 2033-07-06 | Direct | 70,129 |
Reported balance
After 2023-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-07-06 · Grant · Acquired 70,129 · Balance 70,129 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-05-01 | Direct | 30,362 |
Reported balance
After 2024-05-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-05-01 · Grant · Acquired 30,362 · Balance 30,362 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 28,113 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2020 Filed Jun 5, 2020 23:03 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 28,177 | Not disclosed Strike: $6.37 | Not disclosed |
DisclosureSEC source: 0001209191-20-034846 · doc4.xml · derivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,177 Underlying: Common Stock · 28,177 shares Expires 2030-06-02 F2 · price: Not applicable. F1 · derivative.exercise_date: The Option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,081 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012806 · doc4.xml · nonDerivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,062 Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 244 | $92.20 | $22,496.80 |
DisclosureSEC source: 0000899243-20-012806 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,981 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2021, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. F2 · price: Restricted stock units were awarded in lieu of the reporting person's first 2020 quarterly cash retainer payment, with the number of restricted stock units determined by dividing the amount of the cash retainer payment by the Black-Scholes value of a restricted stock unit on the date the grant was made. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 922 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012806 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,737 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2021, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 01:17 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 24,096 | $4.15 | $99,998.40 |
DisclosureSEC source: 0001209191-20-006139 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,305 Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:38 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 11,184 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035570 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,184 Underlying: Common Stock · 11,184 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit shall vest one year from the date of grant. F4 · derivative.expiration_date: The restricted stock unit shall vest one year from the date of grant. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:38 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 23,703 | Not disclosed Strike: $4.80 | Not disclosed |
DisclosureSEC source: 0001209191-19-035570 · doc4.xml · derivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,703 Underlying: Common Stock · 23,703 shares Expires 2029-06-04 F2 · price: Not applicable. F1 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 04, 2019 Filed Jun 7, 2019 01:25 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 10,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035353 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: This restricted stock unit vested on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. F2 · derivative.expiration_date: This restricted stock unit vested on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. Read SEC document |
| June 04, 2019 Filed Jun 7, 2019 01:25 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 10,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035353 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| April 30, 2019 Filed May 1, 2019 20:36 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,043 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-011597 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,815 Read SEC document |
| April 30, 2019 Filed May 1, 2019 20:36 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-011597 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,772 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 30, 2020, which is the first anniversary of the date on which the grant was made. Read SEC document |
| June 06, 2018 Filed Jun 22, 2018 23:00 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 10,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-039314 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Underlying: Common Stock · 10,223 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. F4 · derivative.expiration_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. Read SEC document |
| June 06, 2018 Filed Jun 22, 2018 23:00 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 16,399 | Not disclosed Strike: $6.77 | Not disclosed |
DisclosureSEC source: 0001209191-18-039314 · doc4.xml · derivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,399 Underlying: Common Stock · 16,399 shares Expires 2028-06-05 F2 · price: Not applicable. F1 · derivative.exercise_date: The option shall vest in twelve (12) equal monthly installments on each monthly anniversary of the transaction date with the final vesting date being the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. Read SEC document |
| June 06, 2018 Filed Jul 11, 2018 21:16 UTC Amendment | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 10,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-042369 · doc4a.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Underlying: Common Stock · 10,223 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. F4 · derivative.expiration_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. Read SEC document |
| June 06, 2018 Filed Jul 11, 2018 21:16 UTC Amendment | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 19,242 | Not disclosed Strike: $6.77 | Not disclosed |
DisclosureSEC source: 0001209191-18-042369 · doc4a.xml · derivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,242 Underlying: Common Stock · 19,242 shares Expires 2028-06-05 F2 · price: Not applicable. F1 · derivative.exercise_date: The option shall vest in twelve (12) equal monthly installments on each monthly anniversary of the transaction date with the final vesting date being the earlier of (a) one year from the date of grant, or (b) the day prior to the 2019 Annual Meeting of Stockholders. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 21:11 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-035793 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,853 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vested on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. F2 · derivative.expiration_date: The restricted stock unit vested on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 21:11 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-035793 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:08 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011508 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,987 Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:08 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,043 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011508 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,601 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on May 3, 2019, which is the first anniversary of the date on which the grant was made. Read SEC document |
| June 07, 2017 Filed Jun 13, 2017 01:56 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 15,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-039334 · doc4.xml · derivative · entry 4 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,853 Underlying: Common Stock · 15,853 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. F5 · derivative.expiration_date: The restricted stock unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. Read SEC document |
| June 07, 2017 Filed Jun 13, 2017 01:56 UTC | CERUS CORP CERS · Entity 5431 | GrantOption Right to Buy · Derivative | 38,005 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0001209191-17-039334 · doc4.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,005 Underlying: Common Stock · 38,005 shares Expires 2027-06-06 F3 · price: Not applicable. F4 · derivative.exercise_date: The option shall vest in twelve (12) equal monthly installments on each monthly anniversary of the transaction date with the final vesting date being the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. Read SEC document |
| June 06, 2017 Filed Jun 13, 2017 01:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 10,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-039334 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: This restricted stock unit vested on the day prior to the 2017 Annual Meeting of Stockholders. F2 · derivative.expiration_date: This restricted stock unit vested on the day prior to the 2017 Annual Meeting of Stockholders. Read SEC document |
| June 06, 2017 Filed Jun 13, 2017 01:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 10,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-039334 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| May 09, 2017 Filed May 10, 2017 20:12 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-012642 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,558 Read SEC document |
| May 09, 2017 Filed May 10, 2017 20:12 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,204 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-012642 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,960 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on May 9, 2018, which is the first anniversary of the date on which the grant was made. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.